SFRO - Société Française de Radiothérapie Oncologique

What SFRO - Société Française de Radiothérapie Oncologique does

SFRO (Société Française de Radiothérapie Oncologique) is a French non-profit learned society (association loi 1901), founded in 1990 and headquartered in Paris, that serves as the national professional body for radiation oncologists and related radiotherapy professionals in France. With 800+ members drawn from university hospitals (CHU/CHG), Unicancer cancer centers, and private practice (FHP/SNRO), SFRO is the only organization uniting all radiotherapy practice settings in France. Its core offerings include RecoRad — the national reference framework for radiotherapy best practices developed with SFPM — the Cancer Radiothérapie journal, an annual congress attracting approximately 1,000 participants, and the RadioTransNet preclinical research network coordinated with INCa support. The society also co-developed the Radiosync mobile/web application with SFjRO to guide patients on managing anticancer therapy interruptions before radiotherapy, and co-hosts the 64th PTCOG Annual Conference in 2026.

The society's business model is membership-driven, with annual dues ranging from €50 (SFRO only) to €140 (joint SFRO-ESTRO membership) plus reduced rates for retired, young, and emerging-economy members. Revenue is supplemented by annual congress registration fees, journal subscription income, continuing medical education programs through AFCOR (created in 1998 with SNRO), and corporate partnerships with pharmaceutical companies including AstraZeneca (Master Class Onco-radiothérapie since 2020) and Janssen. SFRO maintains a small operational staff of 7 employees and is governed by an elected Bureau representing three colleges across practice settings, currently led by Pr Véronique Vendrely for the 2026-2027 term. Strategic engagement with French regulatory authorities (HAS, ASN, INCa, ANSM, CNP Oncologie) and international bodies (ESTRO, PTCOG) underpins its authoritative role in French radiotherapy practice.

From a technology perspective, SFRO operates a Joomla-based membership website (sfro.fr), an interactive national center directory, and the Radiosync reference application. The 2017 national peer review audit framework, co-developed with SFPM, AFPPE, and AFQSR, extends SFRO's role into operational quality assurance. SFRO does not publicly disclose revenue or financial results, consistent with its association loi 1901 non-profit status.

Name

SFRO - Société Française de Radiothérapie Oncologique

Legal name

Société Française de Radiothérapie Oncologique

Website

https://sfro.fr

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

SFRO is the French national learned society for radiation oncology, founded in 1990, uniting 800+ radiation oncologists and medical physicists across hospitals, cancer centers, and private practice. It provides national clinical guidelines (RecoRad), the Cancer Radiothérapie journal, an annual congress, and patient tools like Radiosync.

Ownership category

akta.pro rank

Product category

Radiation Oncology Professional Society

NAICS

Other Scientific and Technical Consulting Services (54169)

akta.pro industry

PRIMARYHLAKAFAC

Radiation Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYEUAKAIAD

Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology)

Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)

SECONDARYEUAKAEAC

Quality Assurance Programs & Nuclear Quality Standards (ASME NQA-1, ISO 9001, IAEA)

Energy, Utilities & Environment/Nuclear Energy/Nuclear Safety, Regulation, Licensing & Quality Assurance

Keywords

• Radiation oncology
• Clinical practice guidelines
• Professional medical society
• Continuing medical education
• Oncology research programs

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Dues: Annual membership fees form the core revenue stream. SFRO-only membership costs €50/year, while joint SFRO-ESTRO membership costs €140/year. Reduced rates available for retired members and those in emerging economies. Young member category also available.
2. Congress and Event Revenue: Annual congress with registration fees (discounted for members up to €190). Scientific day events (€50 for curiethérapie day). PTCOG conference co-hosted with fees starting from €300.
3. Journal Subscriptions: Members receive discounted or free access to Cancer Radiothérapie journal and Radiotherapy & Oncology (Green Journal via ESTRO). Paper version subscriptions available at reduced rates.
4. Corporate Partnerships and Sponsorships: Pharmaceutical companies like AstraZeneca and Janssen sponsor the society through annual partnerships, webinars, and event sponsorship. Contact: [email protected]

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

SFRO is the French national learned society for radiation oncology, providing its 800+ members with national clinical practice guidelines (RecoRad), a mobile/web application (Radiosync), an annual congress, accredited continuing education (AFCOR), the Cancer Radiothérapie journal, peer review audits, and the RadioTransNet translational research program. Its core mission is to represent, train, and set quality standards for French radiation oncologists.

Product overview

SFRO (Société Française de Radiothérapie Oncologique) is a French medical society for radiation oncology rather than a commercial product company. Its portfolio consists of clinical recommendation platforms (RecoRad), the Radiosync mobile/web application, scientific publications (Cancer Radiothérapie journal), continuing education programs (AFCOR), and professional resources including the annual SFRO Congress, a national center directory, and the RadioTransNet research network. These offerings serve radiotherapy professionals through membership-based access and are complemented by peer review audit programs for quality assurance.

Differentiator

Problem solved

Functional benefit

Brands

• RecoRad: RECOmmandations pour la pratique de la RADiothérapie externe et de la curiethérapie - National reference framework for radiotherapy practices developed by SFRO
• AFCOR
• RadioTransNet
• Radiosync
• Cancer Radiothérapie

Products and services

• RecoRad — National Practice Guidelines

Quantifiable outcome

• 175,000 cancer patients treated annually with radiotherapy in France
• +1 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

17 partnerships are on record, tiered core and major.

• ESTRO (European Society for Radiotherapy & Oncology)coreStrategic or Co-development PartnerJoint membership program where SFRO members can access ESTRO benefits including the Green Journal (Radiotherapy & Oncology), e-Library, congress replays for 6 months, reduced fees at ESTRO events and courses, open access publication discounts, and eligibility for ESTRO mentorship, awards, and board positions. Joint SFRO-ESTRO membership costs €140/year.
• SFPM (Société Française de Physique Médicale)coreStrategic or Co-development PartnerCollaboration on national practice recommendations (RecoRad), peer audit framework (2017), and preclinical research program (RadioTransNet). Joint editorial work on radiotherapy guidelines.
• INCa (Institut National du Cancer)majorStrategic or Co-development PartnerCollaborates with SFRO on radiotherapy practice recommendations and coordinates preclinical research program RadioTransNet. Works together on innovative technique validation methodologies.
• SNRO (Syndicat National des Radiothérapeutes Oncologues)coreStrategic or Co-development PartnerRepresents private practice radiation oncologists. SNRO members are represented on the SFRO Bureau through the liberal college (Collège FHP/UNAP). Jointly created AFCOR for continuing education.
• AFCOR (Association de Formation Continue en Oncologie Radiothérapie)majorStrategic or Co-development PartnerCreated by SFRO and SNRO in 1998 to provide mandatory continuing medical education and preparation for recertification of radiation oncology professionals.
• AFPPE (Association Française du Personnel Paramédical d'Electroradiologie)majorStrategic or Co-development PartnerPartner in the national peer audit framework established in 2017 for radiotherapy quality assurance. Also collaborates on annual congress workshops.
• AFQSR (Association Française de la Qualité et la Sécurité des soins en Radiothérapie)majorStrategic or Co-development PartnerCo-founder of the national peer audit framework for radiotherapy alongside SFRO, SFPM, and AFPPE. Collaborates on congress sessions.
• RadioTransNetmajorStrategic or Co-development PartnerPreclinical radiotherapy research program coordinated by SFRO with SFPM support and INCa funding, promoting technology transfer from research to clinical application.
• SFjRO (Société Française des Jeunes Radiothérapeutes Oncologues)coreStrategic or Co-development PartnerJointly developed Radiosync mobile application with SFjRO to guide patients on pausing anticancer therapies before radiotherapy. Young members can join SFRO at reduced rates.
• HAS (Haute Autorité de Santé)majorStrategic or Co-development PartnerCollaborated on original radiotherapy procedure guide (2007) alongside INCa and IRSN. Currently working with SFRO to adapt validation methodology for new radiotherapy techniques.
• ASN (Autorité de Sûreté Nucléaire)majorStrategic or Co-development PartnerCollaborates with SFRO on radiotherapy quality standards and is working with INCa and CNP to adapt methodologies for innovative radiotherapy techniques.
• UnicancercoreStrategic or Co-development PartnerNetwork of French cancer centers whose radiation oncologists are represented on the SFRO Bureau through the Unicancer college.
• CNP OncologiemajorStrategic or Co-development PartnerNational Professional Council of Oncology with which SFRO works directly on practice guidelines and professional standards. SFRO is linked to the new CNP d'Oncologie.
• AstraZenecamajorGTM or Marketing PartnerAnnual partner sponsoring SFRO activities. Organizes Master Class Onco-radiothérapie program (since 2020) for scientific exchanges and best practices in thoracic radiotherapy. 23 Phase III clinical trials ongoing in lung cancer as of 2023. Also supports early detection projects and patient education platforms.
• Janssen (Johnson & Johnson)majorGTM or Marketing PartnerCorporate partner of SFRO, acknowledged on the website alongside AstraZeneca as supporting the society's activities.
• PTCOG (Particle Therapy Cooperative Group)majorStrategic or Co-development PartnerSFRO co-hosts the 64th Annual PTCOG Conference (June 8-13, 2026) in Deauville, France, the premier global meeting for particle therapy research and clinical practice.
• SOFOM / SFCOmajorStrategic or Co-development PartnerCollaborates with Société Française d'Oncologie Médicale (SOFOM) and Société Française de Chirurgie Oncologique (SFCO) as part of the French oncology ecosystem. Also works with organ-specific societies.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ESTRO - European Society for Radiotherapy & Oncology: Pan-European learned society for radiation oncology with which SFRO has a joint membership program. Directly comparable as a radiotherapy professional society offering guidelines, journals, congresses, and accreditation to radiation oncologists and medical physicists across Europe.
• AFQSR - Association Française de la Qualité et la Sécurité des soins en Radiothérapie: French association for radiotherapy quality and safety, co-founder with SFRO of the 2017 national peer review audit framework. Closely overlapping scope in radiotherapy quality assurance and clinical audit.
• ASTRO - American Society for Radiation Oncology: The largest radiation oncology professional society globally, headquartered in the US. Direct functional peer: develops clinical guidelines, runs a major annual meeting, publishes the Red Journal, and accredits radiation oncology practice — the same activities SFRO performs for France.
• SFjRO - Société Française des Jeunes Radiothérapeutes Oncologues: French society for junior/trainee radiation oncologists, closely linked to SFRO and co-developer of the Radiosync patient application. A direct peer serving the same specialty pipeline with overlapping membership.
• SFPM - Société Française de Physique Médicale: French national society for medical physicists and SFRO's closest co-development partner on RecoRad, RadioTransNet, and the 2017 national peer audit framework. Operates as a parallel professional society serving the same radiotherapy ecosystem in France.
• SNRO - Syndicat National des Radiothérapeutes Oncologues: National trade union for French radiation oncologists, particularly those in private practice. Represents the same specialty, with members cross-represented on SFRO's Bureau via the FHP/UNAP college.

Regional players

• RANZCR Faculty of Radiation Oncology: Australia and New Zealand's faculty of radiation oncology within RANZCR. Performs the same role as SFRO (training, guidelines, professional standards) for radiation oncologists across Australia and New Zealand.
• CARO - Canadian Association of Radiation Oncology: Canadian national professional association for radiation oncologists. Functions as a directly analogous national radiation oncology society but in a different geography, with similar guideline, education, and advocacy missions.
• JASTRO - Japanese Society for Radiation Oncology: Japanese national learned society for radiation oncology, providing guidelines, annual meetings, and specialty representation in Japan. Comparable national-level radiation oncology society operating in a distinct geography.

Others

• INCa - Institut National du Cancer: French national cancer agency that funds RadioTransNet, co-develops RecoRad-adjacent methodologies, and is a key strategic counterpart for SFRO. Not a competing society but a major funder and policy counterpart in the same radiotherapy ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sfro-soci-t-fran-aise-de-radioth-rapie-oncologique

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SFRO - Société Française de Radiothérapie Oncologique